Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

DNA Analysis Speeds Up Identification of Pathogenic E. coli

By Labmedica staff writers
Posted on 24 Mar 2008
New genetic techniques have enabled scientists to test the DNA of Escherichia coli (E. More...
coli) and to examine very small genetic changes called single nucleotide polymorphisms (SNPs). Using these SNPs, scientists analyzed 96 markers, making genetic analysis of pathogenic bacteria possible at a rate never before accomplished.

E coli produce toxins, called Shiga toxins, which are responsible for illness in infected people. These toxins block protein synthesis, an essential cellular function, particularly in the kidneys. The scientists found that the different clades (groups of organisms from a single ancestor) produced different kinds of Shiga toxins in varying amounts based on their DNA. The individual bacteria could be separated into nine major clades.

The bacteria usually come from animal waste that has contaminated human sources of food or water. Finding out how the bacteria entered the food source always has been a challenge, but now food safety experts can use DNA in the same manner that police use DNA at crime scenes. Scientists will be able to identify those bacteria making people sick, find out where they entered the food source, and use this information to reduce the contamination.

"It used to take three months to score one gene individually,” said Thomas Whittam, Hannah Distinguished Professor at the National Food Safety and Toxicology Center at Michigan State University (NFSTC; East Lansing, MI, USA). "Now, we are working on a new, more rapid system that can do thousands of genes per day.”

In a study reported in the March 2008 issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS), Prof. Whittam and colleagues examined DNA of more than 500 strains of a particularly dangerous member of the E. coli family, O157:H7. "For the first time, we know why some outbreaks cause serious infections and diseases and others don't,” Prof. Whittam said. "The different E. coli groups produce different toxins. Now, we are working on a new, more rapid system that can do thousands of genes per day.”

Prof. Whittam also has plans to use the methodology to study other bacterial strains, such as Shigella, a major cause of diarrhea around the world. "This new equipment can be used to identify hundreds of thousands of pathogenic bacteria,” he said.


Related Links:
National Food Safety and Toxicology Center at Michigan State University

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.